Sign in

CIK 0001439222

  • Large accelerated filer

AGIOS PHARMACEUTICALS, INC.

Sign in to watch
Ticker
AGIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 617-649-8600
Business address
88 SIDNEY STREET, CAMBRIDGE, MA, 02139
Former names
AGIOS PHARMACEUTICALS INC
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Open-market sale Director sold 2,000 shares at an average $50.87 ($101,730)
  6. 4 Open-market sale Chief Executive Officer sold 3,000 shares at $50.02 ($150,060)
  7. 4 Derivatives Options or other derivatives
  8. 3 Insider Initial Statement of Ownership
  9. 4 Open-market sale Director sold 2,036 shares at an average $47.10 ($95,885)
  10. 4 Open-market sale Chief Executive Officer sold 3,000 shares at $50.06 ($150,180)
  11. 4 Open-market buy 10% owner bought 624,575 shares at $49.50 ($30,916,463)
  12. 4 Open-market sale Director sold 5,090 shares at an average $54.37 ($276,753)
  13. 4 Open-market sale Chief Scientific Officer sold 2,146 shares at $58.03 ($124,532)
  14. 4 Open-market sale Chief Executive Officer sold 3,000 shares at $58.62 ($175,860)
  15. 4 Open-market sale Director sold 2,036 shares at an average $53.11 ($108,132)
  16. 4 Open-market sale Chief Scientific Officer sold 6,438 shares at $55.00 ($354,090)
  17. 4 Open-market sale Director sold 40,599 shares at an average $50.84 ($2,064,209)
  18. 4 Open-market sale Chief Executive Officer sold 3,000 shares at $50.47 ($151,410)
  19. 4 Open-market sale Director sold 243,082 shares at an average $49.36 ($11,997,896)
  20. 4 Open-market sale Director sold 135,364 shares at an average $49.37 ($6,683,464)

Page 25 of 38 · 758 filings